Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,735.50
+72.00 (2.70%)
Jul 6, 2026, 3:30 PM JST
Kyowa Kirin Earnings Call Transcripts
Fiscal Year 2025
-
Revenue and profits declined year-over-year due to restructuring and special retirement costs, but key products like Crysvita and Poteligeo showed strong growth in North America and EMEA. R&D pipeline advanced with promising data for Ziftomenib and Rocatinlimab, and AI-driven strategies are boosting market penetration.